Frederick Reinhart Image

Frederick Reinhart

is a past president of the Association of University Technology Managers (AUTM), a global professional organization that advocates for development and commercialization of academic discoveries and trains the skilled practitioners who facilitate the movement of novel technology to the private sector for further development. He does not receive compensation from nor hold equity in any individual pharmaceutical or biotechnology company except such equity as may be part of a mutual fund. He has never received royalties or other compensation resulting from the sale of any therapeutic drug or vaccine.

Recent Articles by Frederick Reinhart

Knowledge Ecology International Letter Misleads on March-In Rights

Recently, Knowledge Ecology International sent to Congress a letter objecting to the draft “Green Paper on Unleashing American Innovation” disseminated by the National Institute of Standards and Technology (NIST) in December, 2018. The KEI letter was signed by 10 other organizations* (the Organizations). The letter, unfortunately, is full of misstatements, distortions, falsehoods and disingenuous arguments. It would be easier to focus on the letter’s one accurate statement:  that high drug prices are a serious concern for people everywhere. It is very unfortunate that KEI, in my opinion, utilizes tactics which continually sacrifice fair and constructive dialog in favor of apparently achieving goals “by any means necessary.” The most disturbing element of the letter is KEI’s advocacy of inappropriate and unjustified use of government march-in rights under the Bayh-Dole Act as a purported means of controlling drug prices. In doing so KEI and the Organizations are threatening medical advances and thereby undermining their own missions.